Index Rebalancing and the Passive Patsies – The Hidden Costs and Biases of Rebalancing
Introduction: Private Equity, IPOs, Price to Sales & the Passive Patsies Revisited The Abundance of the Absurd in the World of Index Rebalancing The Consequences of Expensive Additions Conclusion ...
When the Top Decile is the Bottom of the Barrel
Introduction: Price to Sales & “A Talk with Scott McNealy” The Pittance of Profits among the Top Decile of Price to Sales The Catastrophic Consequences of Buying the Top ...
Short Sellers’ Low Quality Signal (LQS) – A Loss Avoidance Aid for Short Sellers of Low Quality Firms
Introduction to LQS: A Safety Mechanism to Help Protect Short Sellers of Low Quality Firms Low Quality Signal (LQS) Characteristics and Persistence LQS Impact of Performance on: Trading Shorts, ...
IPOs, Index Inclusions and the Passive Patsies – The Cost of Ebullient IPOs to Passive Players
Introduction: Is the New IPO Boom Really Improved? The Atypical Nature of Current IPO Index Inclusions Price to Sales = Problems Simple Measures for Good Measure More Rubble to ...
Growth vs. Value Part II Using Kailash Constructs to Amplify the Eventual Mean Reversion
Introduction: Part 1 Recap The Case for Kailash Value Picks The Case for Kailash Growth Picks The Compelling History of our Top Ranked Value vs. Bottom Ranked Growth Conclusion ...
Growth vs. Value – A Predisposition towards the Importance of Price has been Painful
Introduction: The Historical Context of the Pain Trade for Value Oriented Investors Trouble Comes in Threes Could the Glamour in Growth Lose its Glow? Conclusion Exhibits Introduction: The Historical ...
Dividend Growers: Performance Since 2006
Fig.1: Since 2006 Kailash's Dividend Long Picks have Added 2-3% Battling Average Improvement...
Amazon: Notes from Agnostics The Lost Impact of Large Numbers
Introduction: Keeping it Simple A Bankable Year: How Much “Free” is in Free Cash Flow? The Lost Impact of Large Numbers: What does $26.666 Billion Mean? Conclusion: The Munificence ...
The Defense Dilemma Revisited – Proof From the Past and Picks For the Present
Introduction: Better a Seller Than a Buyer Be The Defense Dilemma Revisited Defensive Boost to Positive Earners Conclusion Exhibits Appendix: R1000 Introduction: Better a Seller Than a Buyer Be ...
Better a Seller than a Buyer Be? – The Buffett Valuation Metric & the Notion of “Cheap at the Peak”
Introduction: Market Cap to GDP Appears Pricey The Numbers Required to Resolve Market Cap to GDP are Anything but Pretty How the Recent Rout Stacks Up vs. History Is ...
Private vs. Public Markets – Identifying Potential Sources of Risk and Reward
Introduction: The Pension Fund Propellant The Appeal of Private Equity’s Purported Promise The Complications of Competition The Concern with IPOs: A Seller’s Market Dry Powder Targets: Potential Winners Conclusion ...
Biotech Update: Revisiting our 2015 Report – A Similar but Slightly Less Compelling Conclusion
Introduction Biotech: M&A and IPO Data Update Valuation: A Biohazard in Biotech? Conclusion: Finding Opportunity in Biotech Appendix: Does Valuation Matter Within Biotech Introduction Over the last few months ...
